Good points, Bloodwynch. Let's not lose sight of the fact many were happy to pay $17 for JBH not that many months ago.
Unfortunately, being a consumer discretionary, it and Harvey Norman get punished severely due to bad sentiment. Harvey has always produced the goods, made massive profit growths in good and bad times, yet its price remained in the doldrums and Mr Harvey kept pulling his hair out wondering what else he could do to make investors positive.
At the moment, JB is in the same boat: Fundamenals are there, but sentiment is not.
- Forums
- ASX - By Stock
- JBH
- worth selling
worth selling , page-68
Featured News
Add JBH (ASX) to my watchlist
(20min delay)
|
|||||
Last
$87.65 |
Change
2.030(2.37%) |
Mkt cap ! $9.583B |
Open | High | Low | Value | Volume |
$85.65 | $87.71 | $85.65 | $27.48M | 314.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6 | $87.56 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$87.70 | 117 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6 | 87.560 |
1 | 6 | 87.520 |
1 | 3 | 87.500 |
1 | 200 | 87.400 |
1 | 6 | 87.390 |
Price($) | Vol. | No. |
---|---|---|
87.700 | 117 | 1 |
87.720 | 50 | 1 |
87.770 | 1 | 1 |
87.810 | 150 | 1 |
87.840 | 260 | 2 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
JBH (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online